{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:10:32Z","timestamp":1791252632185,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T00:00:00Z","timestamp":1292284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014335","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T20:44:16Z","timestamp":1292359456000},"page":"e14335","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells"],"prefix":"10.1371","volume":"5","author":[{"given":"William","family":"Brazelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny M.","family":"Kreahling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Douglas","family":"Cress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Haura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soner","family":"Altiok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase Inhibitors in cancer therapy.","volume":"10","author":"AA Lane","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.","volume":"409","author":"N Khan","year":"2008","journal-title":"Biochem J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/94.7.504","article-title":"Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.","volume":"94","author":"X Yu","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.","volume":"21","author":"CF Deroanne","year":"2002","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0955-0674(94)90060-4","article-title":"Cdc2 regulatory factors.","volume":"6","author":"TR Coleman","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","article-title":"Cyclin-dependent kinases: engines, clocks, and microprocessors.","volume":"13","author":"DO Morgan","year":"1997","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0955-0674(99)80036-2","article-title":"Regulating the onset of mitosis.","volume":"11","author":"R Ohi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0962-8924(00)01773-6","article-title":"The G2-phase DNA-damage checkpoint.","volume":"10","author":"MJ O'Connell","year":"2000","journal-title":"Trends Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.274.5293.1664","article-title":"Cell cycle checkpoints: preventing an identity crisis.","volume":"274","author":"SJ Elledge","year":"1996","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer.","volume":"3","author":"J Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc1296","article-title":"Targeting the checkpoint kinases: chemosensitization versus chemoprotection.","volume":"4","author":"BB Zhou","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.","volume":"21","author":"H Zhao","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(03)00048-5","article-title":"Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.","volume":"3","author":"CS Sorensen","year":"2003","journal-title":"Cancer Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.277.5331.1501","article-title":"Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.","volume":"277","author":"CY Peng","year":"1997","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1073\/pnas.0806671106","article-title":"The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.","volume":"106","author":"S Peddibhotla","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1200\/JCO.2001.19.8.2319","article-title":"Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms.","volume":"19","author":"EA Sausville","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/1078-0432.664.11.2","article-title":"A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors.","volume":"11","author":"EC Dees","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1517\/13543784.17.9.1331","article-title":"Keeping checkpoint kinases in line: new selective inhibitors in clinical trials.","volume":"17","author":"S Ashwell","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1535-7163.MCT-06-0761","article-title":"Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells.","volume":"6","author":"A Edwards","year":"2007","journal-title":"Mol Cancer Ther;"},{"key":"ref20","first-page":"171","article-title":"p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.","volume":"7","author":"T Mitsudomi","year":"1992","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01202192","article-title":"Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction\/single-strand conformation polymorphism method.","volume":"120","author":"T Kashii","year":"1994","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D","article-title":"Screening the p53 status of human cell lines using a yeast functional assay.","volume":"19","author":"LQ Jia","year":"1997","journal-title":"Mol Carcinog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2008.11.057","article-title":"An HDAC inhibitor, trichostatin A, induces a delay at G2\/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.","volume":"378","author":"EJ Noh","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1158\/0008-5472.CAN-08-3382","article-title":"DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress.","volume":"69","author":"V Leung-Pineda","year":"2009","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4161\/cbt.7.11.6728","article-title":"Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity.","volume":"7","author":"JM Feng","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M803111200","article-title":"Cleavage-mediated activation of Chk1 during apoptosis.","volume":"283","author":"K Matsuura","year":"2008","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.281.5376.533","article-title":"Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.","volume":"281","author":"NS Gray","year":"1998","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1535-7163.MCT-08-0492","article-title":"AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.","volume":"7","author":"SD Zabludoff","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.bjc.6690493","article-title":"Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate.","volume":"80","author":"L Qiu","year":"1999","journal-title":"Br J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/35055010","article-title":"Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.","volume":"3","author":"A Taddei","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4161\/cc.4.5.1690","article-title":"Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin.","volume":"4","author":"AR Robbins","year":"2005","journal-title":"Cell Cycle"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1091\/mbc.11.6.2069","article-title":"Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.","volume":"11","author":"L Qiu","year":"2000","journal-title":"Mol Biol Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.02-1003fje","article-title":"Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.","volume":"17","author":"R Warrener","year":"2003","journal-title":"FASEB J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.onc.1210779","article-title":"Histone deacetylase inhibitors induce mitotic slippage.","volume":"27","author":"FE Stevens","year":"2008","journal-title":"Oncogene"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/sj.onc.1202706","article-title":"Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase.","volume":"18","author":"YS Kaneko","year":"1999","journal-title":"Oncogene"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.","volume":"18","author":"JJ Kovacs","year":"2005","journal-title":"Mol Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"26729","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.","volume":"280","author":"P Bali","year":"2005","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1073\/pnas.241500798","article-title":"Diversity of gene expression in adenocarcinoma of the lung.","volume":"98","author":"ME Garber","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1158\/1535-7163.MCT-06-0388","article-title":"Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.","volume":"6","author":"B Rubio-Viqueira","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:41:21Z","timestamp":1740771681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014335"}},"subtitle":[],"editor":[{"given":"Rory Edward","family":"Morty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014335","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}